Indian shares post best session in over 6 weeks on likely Trump presidential win November 6, 2024 Indian generic drugmaker Dr Reddy's Laboratories' second-quarter profit was hit by one-time ...

Bank of America Securities analyst Neha Manpuria maintained a Buy rating on Dr Reddy’s Laboratories (RDY – Research Report) today and set a ...

Dr. Reddy’s Laboratories announced that ICRA Limited has reaffirmed its credit rating for the company’s bank facilities at [ICRA]AA+ (Stable). This rating applies to the company’s fund-based ...